How to build a cell from scratch
Louise Martin reports on the development of Spud, a new synthetic cell, and the possible uses for synthetic cells.
How to build a cell from scratch
Louise Martin reports on the development of Spud, a new synthetic cell, and the possible uses for synthetic cells.
Sedentary carnivores: when immune systems seek out more
Fin Spragg delves into the evolutionary history and biochemistry of carnivorous plants, linking them to the adaptation of plant immunity.
From prompt to patent: The legal challenge of AI-designed drugs
Louise Martin discusses the integration of AI into drug discovery and the legalities of patenting AI-designed drugs.
There is nothing binary about biological sex
Durva Kamdar discusses how biological sex is defined, highlighting the flaws in the Supreme Court’s definition of “women”.
The rise and rise of GLP-1 weight loss medications: Will they fall?
Louise Martin explores the promise and pitfalls of the weight-loss drugs taking the world by storm, weighing benefits against hidden costs.
Navigating the unpredictable: Mapping the risk of rogue waves
Jemima explores how probabilistic modelling could help ships navigate rogue waves, which while rare and dangerous are now more predictable.
The next milestone in gene therapy may not be what you think
Cleo Turner explores the rise of gene therapy through its history, challenges, applications, and future directions.
I talk, you listen: How communication enables and shapes the “AI bubble”
Elise Wilkinson explores the rise of AI and its implications on safety, economics, and human health overall.
Can we “cure” ageing? An immunological perspective
Eva Knightley explores how ageing reshapes the immune system and the emerging therapies that could help extend healthy life.
Hosting versus chairing: The politics behind the COP31 climate summit
Jemima Dinsley reports on the unprecedented compromise behind COP31 and what it means for global climate diplomacy.
